Cream and Lotion for Diabetic Foot Care Market

Market Overview

The global cream and lotion for diabetic foot care market was valued at USD 450.26 million in 2023. It is estimated to reach USD 877.81 million by 2032, growing at a CAGR of 7.7% during the forecast period (2024–2032). In recent years, owing to lifestyle changes and the adoption of unhealthy diets, there has been a rise in the prevalence and incidence of diabetes, which is anticipated to drive the global cream and lotion for the diabetic foot care market. The growing awareness regarding foot care amongst the diabetic population is projected to fuel the market expansion. Moreover, the launch of novel foot creams and lotions used by diabetes patients is estimated to create opportunities for market growth.

Creams and lotions for diabetic foot care are specially formulated skincare products created to address the unique needs of individuals with diabetes. These products typically contain ingredients such as moisturizers, emollients, and skin protectants to help prevent dryness, cracking, and infection, which are common complications of diabetes. Exfoliating dead skin cells and encouraging skin regeneration, which helps with wound healing, creams, and lotions may contain chemicals like urea or lactic acid.

Some formulations may include ingredients with antimicrobial properties to prevent infections, as diabetic individuals are more prone to foot infections due to reduced circulation and nerve damage. Regularly applying these creams and lotions as part of a comprehensive foot care routine can help diabetic individuals maintain healthy, moisturized skin, lower the risk of complications, and boost overall foot health.

Highlight

• North America is estimated to be the largest shareholder in the market

Market Dynamics

Global Cream and Lotion for Diabetic Foot Care Market Drivers:

Increasing Diabetic Population

The increasing diabetic population worldwide is a significant driver for the cream and lotion market for diabetic foot care. For instance, in 2021, the International Diabetes Federation revealed that there were 537 million adults worldwide, representing a prevalence of 1 in 10 individuals living with diabetes. The estimated number is expected to rise to 644 million by 2030 and 784 million by 2045. Similarly, a substantial proportion of the adult population (44%), up to 240 million people, are unaware of their diabetes diagnosis. The absence of a proper diagnosis has led to 6.7 million deaths in the year 2021. The majority of persons suffer from type 2 diabetes.

Additionally, the International Diabetes Federation (IDF) reports that around 541 million persons are at an increased risk of developing type 2 diabetes. With diabetes prevalence on the rise globally, there's a growing demand for specialized products to manage associated complications like diabetic foot ulcers. This demographic trend underscores the urgent need for effective foot care solutions tailored to the unique needs of diabetic patients, highlighting the importance of creams and lotions in maintaining foot health and preventing debilitating complications.

Growing Awareness

Growing awareness among diabetic patients regarding the importance of foot care is pivotal in driving the cream and lotion market for diabetic foot care. Healthcare providers and diabetes educators are increasingly emphasizing the significance of regular foot care routines to prevent complications such as neuropathy and ulcers. Patients are becoming more educated about the risks associated with diabetes-related foot problems and are actively seeking products to manage and prevent them.

Moreover, advocacy groups and awareness campaigns are further disseminating information about the importance of foot care in diabetes management, thereby fostering a proactive approach among patients. This heightened awareness translates into a growing demand for specialized products like creams and lotions designed specifically for diabetic foot care, as patients prioritize preventive measures to maintain foot health and enhance their overall quality of life.

Global Cream and Lotion for Diabetic Foot Care Market Restraint:

Regulatory Constraints 

Regulatory constraints pose significant barriers to the cream and lotion market for diabetic foot care. Stringent regulations govern the development, manufacturing, labeling, and marketing of healthcare products, particularly those targeted at diabetic patients due to safety concerns. Compliance with these regulations entails rigorous testing, documentation, and approval methods, which can be time-consuming and costly for manufacturers.

Additionally, variations in regulatory requirements across different regions and countries further complicate market entry and expansion efforts. Ensuring adherence to standards such as Good Manufacturing Practices (GMP) and obtaining necessary certifications adds to the complexity. Thus, navigating the regulatory landscape demands substantial resources and expertise, deterring smaller companies from entering the market and potentially stifling innovation.

Collaborative efforts among industry stakeholders and regulatory bodies are essential to streamline regulatory processes and facilitate market access for safe and effective diabetic foot care products.

Global Cream and Lotion for Diabetic Foot Care Market Opportunities:

Launch of New Products 

The launch of new products in the Cream and Lotion for the Diabetic Foot Care market drives growth by offering innovative solutions to address the specific needs of diabetic individuals. These products often incorporate advanced formulations targeting issues like foot ulcers, neuropathy, dry skin, and circulation problems associated with diabetic foot care. New launches attract consumers seeking improved efficacy, safety, and convenience, expanding the market's reach and stimulating competition among manufacturers to innovate further, ultimately benefiting diabetic patients with a wider array of effective options.

For instance, there is a potential new therapy for healing diabetic foot ulcers (DFUs) that may become available for those with diabetes in the United States.ON101 cream, also known by its brand name Fespixon, was authorized by the Taiwan Food and Drug Administration in 2021 to treat diabetic foot ulcers (DFUs) when applied directly to the skin. Clinical study results have indicated that the wound-healing cream significantly benefits diabetic foot ulcers. Participants in the study had a 60% rate of complete healing during 16 weeks, whereas those using an absorbent wound dressing only achieved a 35% healing rate. Such factors are estimated to create opportunities for market growth.

Regional Analysis

Based on region, the global cream and lotion for diabetic foot care market is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

North America Dominates the Global Market

North America is the most significant global cream and lotion for diabetic foot care market shareholder and is expected to expand substantially during the forecast period. The factors contributing to this are an increasing prevalence of diabetes, favorable reimbursement regulations, and prominent companies operating in the region. As per the Centers for Disease Control and Prevention (CDC), approximately 29.7 million people, which is equivalent to 8.9% of the whole US population, have been diagnosed with diabetes. Moreover, 352,000 persons were 20 years old or younger in the United States who had been diagnosed with diabetes, which corresponds to a rate of 35 per 10,000 young people. This statistic includes a collective of 304,000 persons who have been diagnosed with type 1 diabetes. Therefore, there is a substantial demand for creams and lotions for treating diabetic foot care.

Furthermore, North America has the highest healthcare expenditure worldwide, especially in the United States, where healthcare spending accounts for 17.7% of public expenditure. In 2019, healthcare spending in the United States amounted to USD 3.8 trillion, indicating a 4.6% increase compared to the previous year. Healthcare expenditure for patients with diabetes has increased over time in the region. This is projected to stimulate market expansion.

The Asia-Pacific region holds significant market growth opportunities due to the growing prevalence of diabetes and the improvement of healthcare infrastructure. A study has revealed a considerably higher occurrence of diabetes in the population of India in comparison to previous assessments. Based on a recent study published in the Lancet, it is estimated that the occurrence of diabetes in India is 11.4%, impacting more than 101 million people. Research commissioned by the health ministry found that around 136 million individuals, representing 15.3% of the population, may have pre-diabetes.

Furthermore, as stated in research by the United Nations Population Fund and the International Institute for Population Sciences, the number of individuals aged 60 years and older in 2022 (as of 1 July) was 149 million, accounting for around 10.5% of the nation's population. By 2050, the population will increase twofold to reach 20.8%, with 347 million individuals. Therefore, these factors contribute to the market growth in this region.

Segmental Analysis

The global cream and lotion for diabetic foot care market is segmented by type and sales channel.

Based on type, the global cream and lotion for diabetic foot care market is divided into cream and lotion.

A specialist product called diabetic foot care cream was created to meet the special needs of diabetics, who are more likely to experience foot issues. It can cause poor circulation and nerve damage, which raises the likelihood of foot issues like calluses, ulcers, dry skin, and infections. Diabetic foot care creams are formulated with moisturizers, emollients, and therapeutic agents to nourish and protect the skin, promoting hydration and preventing dryness and cracking. These creams often contain ingredients to promote circulation and soothe discomfort, aiding in preventing and managing foot issues.

Regularly using diabetic foot care cream as part of a comprehensive foot care regimen recommended by healthcare professionals can help individuals with diabetes maintain healthy feet and lessen the risk of complications that could lead to health problems. However, cream-based products have higher efficacy than lotions, which is a vital characteristic of the cream segment, aiding the global cream and lotion for diabetic foot care market growth. Cream products are easy to use, package, and apply — such factors boost the adoption rate of cream products.

Based on sales channels, the global cream and lotion for diabetic foot care market is segmented into direct and distribution channels.

The sale of cream and lotion for diabetic foot care through distribution channels involves strategic planning and efficient execution to reach diabetic patients effectively. Distribution channels typically include pharmacies, medical supply stores, online platforms, and healthcare facilities. Forming alliances with distributors and wholesalers is essential for general availability. Prescription rates can be increased by teaching medical professionals about the advantages of the items.

Marketing campaigns should emphasize the special qualities of the lotion and cream, such as their capacity to increase circulation, prevent infections, and have moisturizing qualities. Moreover, offering discounts or promotional offers can incentivize purchases. Continuous monitoring of sales performance and customer feedback helps refine distribution strategies and product offerings to meet the evolving needs of diabetic patients, ensuring optimal foot care management.

Recent Developments

• May 2023- Indian researchers found that applying esmolol hydrochloride gel (sold as Galnobax and NovaLead) twice a day can greatly enhance the healing process of diabetic foot ulcers, especially in individuals with risk factors that potentially slow down wound closure. Esmolol is a beta-adrenergic receptor blocker with a brief period of action. The FDA has licensed it for cardiac purposes, specifically for short-term treatment of supraventricular tachycardia.
• December 2023- Varco Leg Care, a firm based in New Delhi, introduced its latest product, 'Ulsr Soothe Max,' specifically designed to treat and heal foot ulcers. The product, developed using Varco's Phyto Transdermal Technology;, is a groundbreaking solution that has the potential to facilitate the complete healing and recovery of individuals suffering from foot ulcers, including varicose veins ulcers and diabetic foot ulcers.